Sampre Nutritions Ltd

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low, underperforming its sector significantly. The stock has seen a continuous decline over the past week and is currently below all key moving averages, reflecting ongoing challenges in the market.

Sampre Nutritions has announced its financial results for the quarter ending December 2024, revealing stable performance metrics. The company's stock score has remained unchanged over the past three months, indicating consistent evaluation of its financial standing amidst the competitive FMCG landscape. Stakeholders are encouraged to monitor future developments.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and underperformance compared to its sector. The stock has seen a cumulative drop over recent days and has struggled over the past year, trading below key moving averages.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and a 57.41% decline over the past year. The stock has consistently traded below key moving averages, indicating ongoing challenges in maintaining market position and investor confidence amid a competitive landscape.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and a 57.41% decline over the past year. The stock has consistently traded below key moving averages, indicating ongoing challenges in maintaining market position and investor confidence amid a competitive landscape.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and a 57.41% decline over the past year. The stock has consistently traded below key moving averages, indicating ongoing challenges in maintaining market position and investor confidence amid a competitive landscape.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and a 57.41% decline over the past year. The stock has consistently traded below key moving averages, indicating ongoing challenges in maintaining market position and investor confidence amid a competitive landscape.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low amid significant volatility, experiencing a 5.31% decline today. The stock has dropped 28.78% over the past week and is trading below all major moving averages, reflecting ongoing challenges in the market.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low of Rs. 39.3 amid significant volatility. The stock has seen a 25.04% decline over the past six days and is trading below all major moving averages, reflecting ongoing challenges in its market performance.

Sampre Nutritions, a microcap in the FMCG sector, has hit a new 52-week low amid significant volatility, underperforming its sector. The stock has dropped nearly 18% over the past five days and is trading below key moving averages, reflecting ongoing challenges and a 52% decline over the past year.

Sampre Nutritions has reached a new 52-week low, with its stock price declining significantly over the past four days. The company has faced a challenging year, experiencing a substantial decrease in value compared to the broader market, and is trading below multiple moving averages, indicating a persistent downward trend.

Sampre Nutritions has reached a new 52-week low, with its stock price declining significantly. The company has underperformed in the FMCG sector, experiencing a notable drop over the past year. Currently, it is trading below multiple moving averages, indicating ongoing challenges in the market.

Sampre Nutritions has hit a new 52-week low, with its stock price declining significantly. Over the past year, the company has experienced a substantial drop, contrasting sharply with broader market gains. The stock is trading below multiple moving averages, indicating ongoing challenges in its performance.

Sampre Nutritions has hit a new 52-week low, with its stock price falling significantly on January 20, 2025. The company has struggled over the past year, experiencing a notable decline while the broader market has performed positively, highlighting ongoing challenges in the FMCG sector.

MarketsMOJO has given a 'Sell' call for Sampre Nutrition's stock due to negative sales and profitability trends in the recent quarter. The company has shown potential for growth with higher profit after tax in the half-yearly period, but as a microcap company in the competitive FMCG industry, it may face challenges. Investors should carefully consider the company's financial performance before making any investment decisions.

Sampre Nutritions, a microcap company in the FMCG industry, has seen a significant increase in its stock price, reaching a 52-week high of Rs. 101.17 on November 11, 2024. Despite a 'Sell' rating from MarketsMOJO, the stock has outperformed the sector by 5.09% and has shown consistent growth, making it an attractive investment option.

Sampre Nutrition, a microcap FMCG company, has announced its financial results for the quarter ended March 2024. While the company's PAT has shown a significant improvement, its Net Sales and PAT for the half-yearly period have decreased, indicating a negative trend. MarketsMOJO has given a 'Sell' call for the company's stock.

Sampre Nutrition has reported a strong operating profit of Rs 2.11 crore, the highest in the last five quarters, despite a challenging quarter. The company's PBT, PAT, and EPS have also shown positive trends, indicating effective financial management. However, net sales have declined, posing a concern for future growth.

Sampre Nutrition, a microcap company in the FMCG industry, has reported its financial results for the quarter ending December 2023. While there is a positive trend in profitability with an increase in PAT, there is also a decline in net sales and a negative trend in the company's score. MarketsMOJO has given a 'Sell' call for the stock.